The p16/CDKN2A copy number variation occurs in at least 50 % of IDH1 mutant-bearing high grade chondrosarcomas, and the findings support the concept that the p16/CDKN2A alterations are likely to be associated with disease progression. This evidence concerns the gene IDH1 and chondrosarcoma.